Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Panza

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialG Frasci, V Lorusso, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, F Carpagnano, G Frasci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
British Journal of Cancer|December 1, 1996
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico CampanoP Comella, G Frasci, G De Cataldis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancerG Frasci, V Lorusso, N Panza, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialG Frasci, V Lorusso, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, F Carpagnano, G Frasci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
British Journal of Cancer|December 1, 1996
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico CampanoP Comella, G Frasci, G De Cataldis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancerG Frasci, V Lorusso, N Panza, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Pageof 8